Sinus rhythm restoration after atrial fibrillation: The clinical value of N-Terminal pro-BNP measurements

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 8, 2008, Pages 955-960

  Danicek, Vladimir ^a   Theodorovich, Nick ^a   Bar Chaim, Shmuel ^a   Miller, Asaf ^a   Vered, Zvi ^a   Koren Morag, Nira ^a   Uriel, Nir ^a   Czuriga, Istvan ^c   Shopen, Andrey ^a   Brantriss, Nurit ^a   Kaluski, Edo ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b University of Medicine and Dentistry of New Jersey   (United States)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Atrial fibrillation; Cardioversion; Heart failure; Left atrium; Pro BNP; Sinus rhythm

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; SINUS RHYTHM; TREATMENT FAILURE;

AGED; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTCOME ASSESSMENT (HEALTH CARE); PEPTIDE FRAGMENTS; PROGNOSIS; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 48249115989     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01121.x     Document Type: Article

References (31)

1. van Kimmenade RR, Pinto YM, Bayes-Genis A, Lainchbury JG, Richards AM, Januzzi JL Jr. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol 2006 98 : 386 390.
2. Knudsen CW, Clopton P, Westheim A, Klemsdal TO, Wu AH, Duc P, McCord J, et al. Predictors of elevated b-type natriuretic peptide concentrations in dyspneic patients without heart failure: An analysis from the breathing not properly multinational study. Ann Emerg Med 2005 45 : 573 580.
3. Knudsen CW, Omland T, Clopton P, Westheim A, Wu AH, Duc P, McCord J, et al. Impact of atrial fibrillation on the diagnostic performance of b-type natriuretic peptide concentration in dyspneic patients: An analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005 46 : 838 844.
4. Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2003 92 : 1124 1127.
5. Li J, Wang L. B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels 2006 21 : 137 140.
6. Shin DI, Jaekel K, Schley P, Sause A, Muller M, Fueth R, Scheffold T, et al. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Zeitschrift fur Kardiologie 2005 94 : 795 800.
7. Date T, Yamane T, Inada K, Matsuo S, Miyanaga S, Sugimoto K, Shibayama K, et al. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart (Br Cardiac Soc) 2006 92 : 1623 1627.
8. Tuinenburg AE, Brundel BJ, Van Gelder IC, Henning RH, Van Den Berg MP, Driessen C, Grandjean JG, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999 10 : 827 835.
9. Tsuchida K, Tanabe K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol 2004 44 : 1 11.
10. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 2000 64 : 765 771.
11. Azevedo A, Bettencourt P, Barros H. Demographic, clinical and echocardiographic determinants of B-type natriuretic peptide plasma concentration. A population-based study. Rev Port Cardiol 2007 26 : 105 113.
12. Lee SH, Jung JH, Choi SH, Lee N, Park WJ, Oh DJ, Rhim CY, et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 2006 70 : 100 104.
13. Kim BJ, Hwang SJ, Sung KC, Kim BS, Kang JH, Lee MH, Park JR. Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function. Int J Cardiol 2007 118 : 145 150.
14. Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol 2005 105 : 31 39.
15. Gould PA, D'Agostino J, Schneider HG, Kaye DM. Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure. Eur J Heart Fail 2006 8 : 263 269.
16. Buob A, Jung J, Siaplaouras S, Neuberger HR, Mewis C. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2006 29 : 559 563.
17. Vinch CS, Rashkin J, Logsetty G, Tighe DA, Hill JC, Meyer TE, Rosenthal LS, et al. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology 2004 102 : 188 193.
18. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004 93 : 1555 1558.
19. Jourdain P, Bellorini M, Funck F, Fulla Y, Guillard N, Loiret J, Thebault B, et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: A hormonal study. Eur J Heart Fail 2002 4 : 263 267.
20. Albage A, Kenneback G, Van Der Linden J, Berglund H. Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure. Ann Thorac Surg 2003 75 : 790 795.
21. Watanabe M, Murakami M, Furukawa H, Nakahara H, Tanaka H, Sunamori M. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. J Heart Valve Dis 2003 12 : 287 291.
22. Yamada T, Murakami Y, Okada T, Okamoto M, Shimizu T, Toyama J, Yoshida Y, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation. Am J Cardiol 2006 97 : 1741 1744.
23. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 2004 20 : 1245 1248.
24. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K, Aizawa Y. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state. Jpn Circ J 2001 65 : 788 792.
25. Shimizu H, Murakami Y, Inoue S, Ohta Y, Nakamura K, Katoh H, Sakne T, et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke J Cereb Circ 2002 33 : 1005 1010.
26. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl Med 2004 350 : 655 663.
27. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005 45 : 82 86.
28. Maggioni AP, Latini R, Carson PE, Singh SN, Barlera S, Glazer R, Masson S, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the valsartan heart failure trial (val-heft). Am Heart J 2005 149 : 548 557.
29. Wazni OM, Martin DO, Marrouche NF, Latif AA, Ziada K, Shaaraoui M, Almahameed S, et al. Plasma b-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004 110 : 124 127.
30. Horie H, Tsutamoto T, Minai K, Hayashi M, Kito O, Kinoshita M. Brain natriuretic peptide predicts chronic atrial fibrillation after ventricular pacing in patients with sick sinus syndrome. Jpn Circ J 2000 64 : 965 970.
31. Parthenakis FI, Patrianakos AP, Skalidis EI, Diakakis GF, Zacharis EA, Chlouverakis G, Karalis IK, et al. Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy. Int J Cardiol 2007 118 : 206 214.